People - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

People

PTSM: Pharmaceutical Technology Sourcing and Management
Volume 3, Issue 2

People on the move in February 2007.

Greenwich, CT (Feb. 20)Aptuit, Inc. ( http://www.aptuit.com/) announced a series of promotions and shifting of responsibility in its senior management team. These changes include: Frank J. Wright becomes vice-chairman, responsible for external value creation and global integration activities and also has been nominated to the company's board of managers. Scott L. Houlton becomes chief operating officer, with responsibility for scientific operations, business process Improvement, human resources, clinical operations, and capital development. Michael J. Butler, president, scientific operations, will take responsibility for Aptuit's technology and innovation investment activities, including research and development. And Robert G. Burford, managing director, has assumed additional responsibility as chairman of the management committee of Aptuit Consulting.

InformexUSA, San Francisco (Feb. 14)—Halocarbon Products Corporation (River Edge, NJ, http://www.halocarbon.com/) named Mary Ellen Rubinstein marketing manager with responsibility for three product lines: inhalation anesthetics; fluorochemicals; and oils, greases, and waxes. Halocarbon is a producer of specialty fluorochemicals.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here